Search the Newsreel

Mount Hope Mining Shares Halted Pending Capital Raising Announcement

Charles Schwab holder plans sale of common stock | HOPE SEC Filing - Form 144

David P. Malone, a holder of Charles Schwab Corp common stock, has filed a Form 144 indicating his plan to sell up to 3,483 shares, valued at $50,195.00. The filing also notes previous sales by Malone within the last three months, totaling 6,250 shares …

Hope Bancorp (NASDAQ:HOPE) Hits New 1-Year High - What's Next?

Hope Bancorp (NASDAQ:HOPE) recently reached a new 52-week high of $14.49, with positive analyst sentiment reflected in a "Moderate Buy" rating and an average price target of $15.50. The company reported EPS of $0.27 and revenue of $147.82 million, slightly exceeding expectations, and declared …

Hope Bancorp stock hits 52-week high at $14.48 By Investing.com

Hope Bancorp (HOPE) stock has reached a 52-week high of $14.48, reflecting a 41% total return over the past year and nearly 35% year-to-date gains. The bank, with a $1.85 billion market cap, boasts a P/E ratio of 14.36 and a 7.83% dividend yield, …

Wasatch Advisors LP Buys 186,357 Shares of OrthoPediatrics Corp. $KIDS

Wasatch Advisors LP significantly increased its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 56.6% in the second quarter, purchasing an additional 186,357 shares. This brings their total holdings to 515,677 shares, representing 2.01% of the company. OrthoPediatrics recently reported better-than-expected earnings, with a smaller loss …

Hope Life International Board Sets Date to Review 2026 Interim Results and Dividend

Understanding the Setup: (KIDS) and Scalable Risk

This article provides an in-depth analysis of Orthopediatrics Corp. (NASDAQ: KIDS), highlighting a potential long-term breakout if current strong sentiment holds. It offers AI-generated signals, institutional trading strategies tailored to different risk profiles, and a multi-timeframe signal analysis to guide investors. Key findings indicate …

How (HOPE) Movements Inform Risk Allocation Models

This article analyzes Hope Bancorp Inc. (NASDAQ: HOPE) using AI models, highlighting a weak near-term sentiment but strong mid and long-term outlook. It presents three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss points. The analysis emphasizes risk management …

Dimensional Fund Advisors LP Has $8.67 Million Stake in OrthoPediatrics Corp. $KIDS

Dimensional Fund Advisors LP reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.2% in the first quarter, though it still holds 546,626 shares valued at $8.67 million. Institutional investors collectively own 69.05% of the stock. Analysts generally maintain a "Moderate Buy" rating for OrthoPediatrics, …

Hope Bancorp Inc (HOPE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Hope Bancorp Inc (HOPE) has an earnings forecast score of 7.00, ranking 193 out of 395 in the Banking Services industry, with an average price target of $12.00. Analysts, based on 4 ratings, largely recommend a "Buy" for the stock. The company's expected revenue …

Hope Bancorp, Inc. (HOPE) Stock Forecasts

This article provides a stock forecast for Hope Bancorp Inc. (HOPE), a bank holding company offering financial services. Argus has issued a report on HOPE, which includes a current price of $13.99, a rating, and an earnings estimate. The report also highlights that Hope …

Hope Bancorp Inc (HOPE) Stock News Today

This article provides an overview of Hope Bancorp Inc (HOPE) stock, including its current trading price, market cap, and P/E ratio. It indicates that more news regarding the company's stock, earnings, analyst ratings, and key developments will be available soon. The page serves as …

HOPE Bancorp Inc 2Q 2026: Revenue $147.8M, Net income $33M, EPS $0.26— 10-Q Summary

HOPE Bancorp Inc reported strong second-quarter 2026 results, achieving profitability with $33M in net income and diluted EPS of $0.26, a significant turnaround from a net loss in the prior year. The company saw a 56.6% year-over-year revenue increase to $147.8M, driven by higher …

Hope Bancorp, Inc. $HOPE Shares Sold by Edgestream Partners L.P.

Edgestream Partners L.P. significantly reduced its stake in Hope Bancorp, Inc. (NASDAQ:HOPE) by 88.5% in the first quarter, selling over 80,000 shares. Despite this, institutional investors collectively own 84% of the company, and analysts generally maintain a "Hold" rating with an average target price …

Q2 Rundown: Hope Bancorp (NASDAQ:HOPE) Vs Other Regional Banks Stocks

This article reviews the Q2 performance of regional banks, highlighting Hope Bancorp's mixed quarter with a 10.1% revenue increase. It contrasts Hope Bancorp with top performer OFG Bancorp and weakest performer Banc of California, also touching upon Provident Financial Services and Cathay General Bancorp. …

First Trust Advisors LP Purchases 164,099 Shares of Hope Bancorp, Inc. $HOPE

First Trust Advisors LP significantly increased its stake in Hope Bancorp, Inc. (NASDAQ:HOPE) by purchasing an additional 164,099 shares, bringing its total ownership to 346,196 shares valued at $3.87 million. Other institutional investors have also modified their holdings, with institutional ownership now at 84%. …

Orthopediatrics Corp Q2 2026: Revenue $70.5M, EPS $(0.30) — 10-Q Summary

Orthopediatrics Corp (KIDS) reported its Q2 2026 financial results, with revenue increasing to $70.5 million from $61.1 million year-over-year. The company posted a net loss of $7.16 million and diluted EPS of $(0.30), largely consistent with the previous year. Key growth drivers included Trauma …

OrthoPediatrics Corp. Stock 12‑Month Price Target Raised to $26.67, Implies 28% Upside

Analysts have raised the 12-month average price target for OrthoPediatrics Corp. stock from $25 to $26.67, with individual forecasts ranging from $22 to $35 per share. This new target implies a potential upside of approximately 28% from the Aug. 4 closing price. The consensus …

ORTHOPEDIATRICS CORP : NEEDHAM RAISES TARGET PRICE TO $35 FROM $30

Needham has increased its target price for ORTHOPEDIATRICS CORP (KIDS.O) to $35 from the previous $30. This adjustment indicates a more optimistic outlook by the analyst firm regarding the company's future stock performance. The report was issued by Reuters.

Mount Hope Mining (ASX:MHM) Rises After Mt Solitary Returns 98% Gold Recovery

OrthoPediatrics (Nasdaq: KIDS) lifts 2026 guidance after strong Q2 growth

OrthoPediatrics reported record Q2 2026 net revenue of $70.5 million, marking a 15% increase year-over-year, primarily driven by strong growth in Trauma and Deformity products and international sales. The company also achieved a record adjusted EBITDA of $6.8 million and significantly improved free cash …

Hope Bancorp Inc. (HOPE) director sells 26,995 trust-held shares

Hope Bancorp Inc. director Daisy Y. Ha sold 26,995 shares of common stock at $14.245 per share on August 3, 2026. The shares were held indirectly through the Kim Ha Living Trust, which now holds 346,120 shares. Ha also holds shares directly and through …

OrthoPediatrics: Q2 Earnings Snapshot

OrthoPediatrics Corp. (KIDS) reported a Q2 loss of $7.2 million, or 30 cents per share, which adjusted to 26 cents per share. The medical device maker posted revenue of $29.5 million for the quarter and expects full-year revenue to be between $125 million and …

OrthoPediatrics (NASDAQ: KIDS) eyes $265M–$269M 2026 revenue, cash breakeven

OrthoPediatrics Corp. (NASDAQ: KIDS) is projecting 2026 revenue between $265 million and $269 million, alongside an Adjusted EBITDA of approximately $25 million and roughly breakeven free cash flow. This outlook is detailed in an investor update that also highlights the company's focus on the …

Nearly 46,000 children helped as OrthoPediatrics revenue hits $70.5M

OrthoPediatrics (Nasdaq: KIDS) reported record Q2 2026 revenue of $70.5 million, a 15% year-over-year increase, driven by strong growth in U.S. and international markets, particularly in its Trauma & Deformity segment. The company helped nearly 46,000 children and achieved a record adjusted EBITDA of …

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

OrthoPediatrics Corp. announced strong financial results for the second quarter of 2026, with record total revenue of $70.5 million, marking a 15% year-over-year increase, and record adjusted EBITDA of $6.8 million. The company helped nearly 46,000 children and significantly reduced free cash flow usage. …

Hope Bancorp (HOPE) Earnings Turnaround Puts Its Valuation Back In Focus

Hope Bancorp (HOPE) has seen renewed investor interest following a strong second-quarter earnings report, which included affirming its dividend, reducing net charge-offs, and completing a share repurchase tranche. The company's stock has shown positive momentum, with a 4.49% 30-day return and a 29.23% year-to-date …

Hope Bancorp (HOPE) trust plans $378K NASDAQ stock sale under Form 144

KIM HA LIVING TRUST, a shareholder of Hope Bancorp (HOPE), plans to sell 26,995 shares of common stock on NASDAQ, valued at approximately $378,199.95, through Fidelity Brokerage Services LLC on August 3, 2026. This intention was disclosed in a Form 144 SEC filing. The …

Hope Bancorp, Inc. (NASDAQ:HOPE) Receives Consensus Rating of "Hold" from Brokerages

Hope Bancorp (NASDAQ:HOPE) has received a consensus "Hold" rating from brokerages, with an average 12-month price target of $15.50. The company recently reported quarterly EPS of $0.27, beating estimates, and will issue a quarterly dividend of $0.14 per share. Insider trading activity and institutional …

HOPE|Hope Bancorp Inc|Price:14.165|Chg%:+0.155

Hope Bancorp Inc. (HOPE) shows healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Banking Services industry. Institutional ownership is notably high, and analysts have issued "Buy" ratings with a target price of $15.25. Despite strong recent performance, technical …

OrthoPediatrics (NASDAQ:KIDS) Issues Earnings Results

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

HOPE Maintained by Keefe, Bruyette & Woods -- Price Target Raised to $15

Keefe, Bruyette & Woods analyst Kelly Motta maintained a "Market Perform" rating for Hope Bancorp (HOPE) while raising its price target from $14.00 to $15.00. Despite the price target increase, the stock is considered 19.7% overvalued according to GuruFocus's GF Value™ of $11.85, and …